News

E-Tryton Italy is one of four registries in Europe evaluating the Tryton Side Branch Stent System in real-world clinical settings. Tryton Medical claims that its Side Branch Stent

B Braun claims that the availability of 1g and 2g Cefepime in the Duplex System means faster, safer and accurate administration of Cefepime to patients as it can

Clopidogrel is the active ingredient in Plavix, an orally available antiplatelet drug, which currently is marketed by Bristol-Myers Squibb and Sanofi-Aventis. The joint decision provides CyDex with full

LIPO-102 is Lithera’s novel injectable combination of salmeterol xinafoate (SX) and fluticasone propionate (FP) for selective, non-ablative fat reduction. LIPO-102 is currently under development for the treatment of

As per the agreement, Synosia will be responsible for SYN-115 and SYN-118 through Phase II clinical development. UCB will be responsible for Phase III clinical development and commercialisation.

The patent application was among the assets Columbia Laboratories sold to Watson in July 2010. The patent will cover Crinone and Prochieve (progesterone gels) and any products in

As per the new seven year supply agreement, Caliper Life Sciences is expected to continue to be the exclusive supplier of the microfluidic chips used in Agilent’s Bioanalyzer

The objective of the Folotyn Phase 2b study (PDX-012) was to estimate the efficacy of Folotyn relative to that of erlotinib as assessed by OS, the primary endpoint

Lathbury is expected to report to Steven Hagen, vice president of Pharmaceutical Development and Manufacturing. Lathbury will assume leadership for AMRI’s Chemical Development business including operations in Albany,